Lawrence K. Cohen
InvestorChief Executive Officer at Health2047
Find your path to Lawrence
Sign up to see every warm intro you have to Lawrence
- Paths you didn't know you had: your email and LinkedIn already hold routes to Lawrence. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Larry Cohen is CEO of Health2047, an experienced biotechnology leader focused on drug and platform development. He previously held executive roles at Kadmon Holdings, VIA Pharmaceuticals, Zyomyx, Progenitor, and Somatix, and holds a PhD in Microbiology from the University of Illinois with postdoctoral work at Dana-Farber and Harvard Medical School.
Colleagues at Health2047
Frequently asked questions
- Who is Lawrence K. Cohen?
- Larry Cohen is CEO of Health2047, an experienced biotechnology leader focused on drug and platform development. He previously held executive roles at Kadmon Holdings, VIA Pharmaceuticals, Zyomyx, Progenitor, and Somatix, and holds a PhD in Microbiology from the University of Illinois with postdoctoral work at Dana-Farber and Harvard Medical School.
- Where does Lawrence K. Cohen work?
- Lawrence K. Cohen is Chief Executive Officer at Health2047.
About this profile. Compiled from public sources — Health2047's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








